-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ID+9p6GViiShwdvbcHfefB+JctzaXZj4wp+FK1H5ddNa3IxUwYIVZh1VO52tW7zi 586XG+7l4vAeFOyKj7+gVQ== 0000950134-06-003297.txt : 20060217 0000950134-06-003297.hdr.sgml : 20060217 20060217134514 ACCESSION NUMBER: 0000950134-06-003297 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060217 DATE AS OF CHANGE: 20060217 GROUP MEMBERS: AMADEUS II A LP GROUP MEMBERS: AMADEUS II AFFILIATES FUND LP GROUP MEMBERS: AMADEUS II B LP GROUP MEMBERS: AMADEUS II C LP GROUP MEMBERS: AMADEUS II D GMBH & CO KG SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Solexa, Inc. CENTRAL INDEX KEY: 0000913275 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 943161073 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-45671 FILM NUMBER: 06628318 BUSINESS ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5106709300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: LYNX THERAPEUTICS INC DATE OF NAME CHANGE: 19931008 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Amadeus Capital Partners LTD CENTRAL INDEX KEY: 0001320652 IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: MOUNT PLEASANT HOUSE, 2 MOUNT PLEASANT STREET 2: HUNTINGDON ROAD CITY: CAMBRIDGE STATE: X0 ZIP: CB3 ORN BUSINESS PHONE: 44 (0)1223-7007-000 MAIL ADDRESS: STREET 1: MOUNT PLEASANT HOUSE, 2 MOUNT PLEASANT STREET 2: HUNTINGDON ROAD CITY: CAMBRIDGE STATE: X0 ZIP: CB3 ORN SC 13D/A 1 f17537sc13dza.htm AMENDMENT TO SCHEDULE 13D sc13dza
 

 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934
(Amendment No. 2 )*

SOLEXA, INC.
(Name of Issuer)
COMMON STOCK
(Title of Class of Securities)
83420X 10 5
(CUSIP Number)
Hermann Hauser
c/o Amadeus Capital Partners Limited
Mount Pleasant House, 2 Mount Pleasant
Huntingdon Road
Cambridge, United Kingdom CB3 ORN
(+44 20 7024 6900)
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
January 19, 2006
(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 


 

 

           
1   NAMES OF REPORTING PERSONS:

Amadeus Capital Partners Limited
   
  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):
 
   
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

  (a)   þ 
  (b)   o 
     
3   SEC USE ONLY:
   
   
     
4   SOURCE OF FUNDS (SEE INSTRUCTIONS):
   
  AF
     
5   CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e): N/A
   
  o
     
6   CITIZENSHIP OR PLACE OF ORGANIZATION:
   
  England
       
  7   SOLE VOTING POWER:
     
NUMBER OF   0
       
SHARES 8   SHARED VOTING POWER:
BENEFICIALLY    
OWNED BY   5,028,737
       
EACH 9   SOLE DISPOSITIVE POWER:
REPORTING    
PERSON   0
       
WITH 10   SHARED DISPOSITIVE POWER:
     
    5,028,737
     
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
   
  5,028,7371
     
12   CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): N/A
   
  o
     
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):
   
  13.7%
     
14   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
   
  CO
 
1 See Item 6.    

 


 

 

           
1   NAMES OF REPORTING PERSONS:

Amadeus II A LP
   
  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):
 
   
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

  (a)   þ 
  (b)   o 
     
3   SEC USE ONLY:
   
   
     
4   SOURCE OF FUNDS (SEE INSTRUCTIONS):
   
  OO
     
5   CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e): N/A
   
  o
     
6   CITIZENSHIP OR PLACE OF ORGANIZATION:
   
  England
       
  7   SOLE VOTING POWER:
     
NUMBER OF   0
       
SHARES 8   SHARED VOTING POWER:
BENEFICIALLY    
OWNED BY   5,028,737
       
EACH 9   SOLE DISPOSITIVE POWER:
REPORTING    
PERSON   0
       
WITH 10   SHARED DISPOSITIVE POWER:
     
    5,028,737
     
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
   
  5,028,7371
     
12   CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): N/A
   
  o
     
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):
   
  13.7%
     
14   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
   
  PN

 


 

 

           
1   NAMES OF REPORTING PERSONS:

Amadeus II B LP
   
  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):
 
   
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

  (a)   þ 
  (b)   o 
     
3   SEC USE ONLY:
   
   
     
4   SOURCE OF FUNDS (SEE INSTRUCTIONS):
   
  OO
     
5   CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e): N/A
   
  o
     
6   CITIZENSHIP OR PLACE OF ORGANIZATION:
   
  England
       
  7   SOLE VOTING POWER:
     
NUMBER OF   0
       
SHARES 8   SHARED VOTING POWER:
BENEFICIALLY    
OWNED BY   5,028,737
       
EACH 9   SOLE DISPOSITIVE POWER:
REPORTING    
PERSON   0
       
WITH 10   SHARED DISPOSITIVE POWER:
     
    5,028,737
     
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
   
  5,028,7371
     
12   CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): N/A
   
  o
     
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):
   
  13.7%
     
14   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
   
  PN

 


 

 

           
1   NAMES OF REPORTING PERSONS:

Amadeus II C LP
   
  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):
 
   
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

  (a)   þ 
  (b)   o 
     
3   SEC USE ONLY:
   
   
     
4   SOURCE OF FUNDS (SEE INSTRUCTIONS):
   
  OO
     
5   CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e): N/A
   
  o
     
6   CITIZENSHIP OR PLACE OF ORGANIZATION:
   
  England
       
  7   SOLE VOTING POWER:
     
NUMBER OF   0
       
SHARES 8   SHARED VOTING POWER:
BENEFICIALLY    
OWNED BY   5,028,737
       
EACH 9   SOLE DISPOSITIVE POWER:
REPORTING    
PERSON   0
       
WITH 10   SHARED DISPOSITIVE POWER:
     
    5,028,737
     
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
   
  5,028,7371
     
12   CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): N/A
   
  o
     
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):
   
  13.7%
     
14   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
   
  PN

 


 

 

           
1   NAMES OF REPORTING PERSONS:

Amadeus II D GmbH & Co KG
   
  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):
 
   
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

  (a)   þ 
  (b)   o 
     
3   SEC USE ONLY:
   
   
     
4   SOURCE OF FUNDS (SEE INSTRUCTIONS):
   
  OO
     
5   CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e): N/A
   
  o
     
6   CITIZENSHIP OR PLACE OF ORGANIZATION:
   
  Germany
       
  7   SOLE VOTING POWER:
     
NUMBER OF   0
       
SHARES 8   SHARED VOTING POWER:
BENEFICIALLY    
OWNED BY   5,028,737
       
EACH 9   SOLE DISPOSITIVE POWER:
REPORTING    
PERSON   0
       
WITH 10   SHARED DISPOSITIVE POWER:
     
    5,028,737
     
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
   
  5,028,7371
     
12   CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): N/A
   
  o
     
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):
   
  13.7%
     
14   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
   
  PN

 


 

 

           
1   NAMES OF REPORTING PERSONS:

Amadeus II Affiliates Fund LP
   
  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY):
 
   
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):

  (a)   þ 
  (b)   o 
     
3   SEC USE ONLY:
   
   
     
4   SOURCE OF FUNDS (SEE INSTRUCTIONS):
   
  OO
     
5   CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e): N/A
   
  o
     
6   CITIZENSHIP OR PLACE OF ORGANIZATION:
   
  Delaware
       
  7   SOLE VOTING POWER:
     
NUMBER OF   0
       
SHARES 8   SHARED VOTING POWER:
BENEFICIALLY    
OWNED BY   5,028,737
       
EACH 9   SOLE DISPOSITIVE POWER:
REPORTING    
PERSON   0
       
WITH 10   SHARED DISPOSITIVE POWER:
     
    5,028,737
     
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
   
  5,028,7371
     
12   CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): N/A
   
  o
     
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):
   
  13.7%
     
14   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
   
  PN

 


 

Item 1. Security and Issuer.
     (a) The class of equity securities to which this statement relates is common stock, par value $0.01 per share (the “Common Stock”), of Solexa, Inc., a Delaware corporation (the “Issuer”).
     (b) The principal executive offices of the Issuer are located at 25861 Industrial Blvd., Hayward, California, 94545.
Item 2. Identity and Background.
Set forth below is the following information with respect to the filing on this Schedule 13D: (a) name; (b) business address; (c) principal occupation and name, business and address of employer; (d) information concerning criminal convictions during the last five years; (e) information concerning civil or administrative proceedings under state or federal securities laws during the past five years with respect to any state or federal securities laws; and (f) citizenship.
     (a) Amadeus Capital Partners Limited (“Amadeus Capital”), Amadeus II ‘A’ (“Amadeus IIA”), Amadeus II ‘B’ (“Amadeus IIB”), Amadeus II ‘C’ (“Amadeus IIC”), Amadeus II ‘D’ GmbH & Co KG (“Amadeus IID”) and Amadeus II Affiliates Fund LP (“Amadeus Affiliates”) (collectively, the “Funds”). Amadeus Capital is the manager of the Funds. The persons named in this paragraph are referred to individually herein as a “Reporting Person” and collectively as the “Reporting Persons.”
     (b) The address of the principal business office of Amadeus Capital, Amadeus IIA, Amadeus IIB, Amadeus IIC, Amadeus IID, and Amadeus Affiliates is c/o Amadeus Capital Partners Limited, Mount Pleasant House, 2 Mount Pleasant, Huntingdon Road, Cambridge, United Kingdom CB3 ORN.
     (c) The principal business of the Funds is to invest in and assist high technology companies in Europe. The principal business of Amadeus Capital is to manage the affairs of the Funds.
     (d) During the five years prior to the date hereof, none of the Reporting Persons has been convicted in a criminal proceeding.
     (e) During the five years prior to the date hereof, none of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction ending in a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or State securities laws or finding any violation with respect to such laws.
     (f) Amadeus Capital is a corporation organized under the laws of England. Each of Amadeus IIA, Amadeus IIB, and Amadeus IIC is a limited partnership organized under the laws of England. Amadeus IID is a limited partnership organized under the laws of Germany. Amadeus Affiliates is a limited partnership organized under the laws of the State of Delaware.
Item 3. Source and Amount of Funds or Other Consideration.
     On March 4, 2005, pursuant to an Acquisition Agreement dated as of September 28, 2004 (the “Acquisition Agreement”), and as amended by an Amendment and Waiver thereto dated as

 


 

of March 3, 2005 (the “Amendment”), by and between Solexa Limited, a company registered in England and Wales (“Solexa Limited”) and the Issuer, the Issuer acquired all of the outstanding share capital of Solexa Limited (the “Business Combination”). As consideration for the outstanding share capital of Solexa Limited, the Issuer issued an aggregate of 14,750,000 shares of Common Stock to holders of the outstanding share capital and options to purchase the share capital of Solexa Limited. The foregoing summary of the Business Combination is qualified in its entirety by reference to the copies of the Acquisition Agreement, filed as Exhibit 2.2 to the Issuer’s Current Report on Form 8-K filed on September 30, 2004 and incorporated herein in its entirety, and the Amendment, filed as Exhibit 2.2.1 to the Issuer’s Current Report on Form 8-K filed on March 7, 2005 and incorporated herein in its entirety by reference.
     As a result of the Business Combination and after taking into account the reallocation of an aggregate of 7,198 shares of Common Stock of the Issuer among the former holders of Solexa Limited Capital Stock, the share capital of Solexa Limited held by Amadeus IIA prior to the Business Combination was exchanged for 1,570,609 shares of Common Stock, the share capital of Solexa Limited held by Amadeus IIB prior to the Business Combination was exchanged for 1,047,074 shares of Common Stock, the share capital of Solexa Limited held by Amadeus IIC prior to the Business Combination was exchanged for 732,952 shares of Common Stock, the share capital of Solexa Limited held by Amadeus IID prior to the Business Combination was exchanged for 34,903 shares of Common Stock and the share capital of Solexa Limited held by Amadeus Affiliates prior to the Business Combination was exchanged for 104,706 shares of Common Stock.
     On April 21, 2005, the Issuer entered into a Securities Purchase Agreement (the “April Purchase Agreement”) by and among the Issuer, the Funds and certain other individuals and entities identified on the signature pagers thereto, for a private placement of Common Stock and warrants to purchase Common Stock. Pursuant to the April Purchase Agreement, the Issuer sold and issued approximately 2,120,000 shares of Common Stock and warrants to purchase up to approximately 1,060,000 shares of Common Stock on April 25, 2005 (the “April Closing”) and approximately an additional 6,005,000 shares of Common Stock and warrants to purchase up to approximately 3,002,000 shares of Common Stock in a second closing on July 12, 2005 (the “July Closing”) following approval of the July Closing by the Issuers stockholders at its 2005 annual meeting of stockholders held on July 7, 2005 (the April Closing and the July Closing are collectively referred to as the “April Private Placement”). Amadeus IIA purchased 346,163 shares of Common Stock at a price of $4.00 and warrants to purchase 173,081 shares of Common Stock with an exercise price of $5.00 per share for a total consideration of approximately $1,384,652.00, Amadeus IIB purchased 230,775 shares of Common Stock at a price of $4.00 and warrants to purchase 115,387 shares of Common Stock with an exercise price of $5.00 per share for a total consideration of approximately $923,100.00, Amadeus IIC purchased 161,543 shares of Common Stock at a price of $4.00 and warrants to purchase approximately 80,772 shares of Common Stock with an exercise price of $5.00 per share for a total consideration of approximately $646,172.00, Amadeus IID purchased 7,693 shares of Common Stock at a price of $4.00 and warrants to purchase 3,847 shares of Common Stock with an exercise price of $5.00 per share for a total consideration of approximately $30,772.00 and Amadeus Affiliates purchased 23,078 shares of Common Stock at a price of $4.00 and warrants to purchase 11,539 shares of Common Stock with an exercise price of $5.00 per share for a total consideration of approximately $92,312.00 at the July Closing. References to and descriptions of the April Purchase Agreement as set forth in this Item 3 are qualified in their entirety by reference to the April Purchase Agreement filed as Exhibit 10.58 to the Issuer’s Current Report on Form 8-K filed on April 26, 2005 and is incorporated herein in its entirety by reference.
     Additionally, on November 18, 2005, the Issuer entered into a Securities Purchase Agreement (the “November Purchase Agreement”) by and among the Issuer, the Funds and certain other individuals and entities identified on the signature pagers thereto, for a private placement of Common Stock and warrants to purchase Common Stock. Pursuant to the

 


 

November Purchase Agreement, the Issuer sold and issued approximately 3,850,000 shares of Common Stock and warrants to purchase up to approximately 1,350,000 shares of Common Stock on November 23, 2005 (the “November Closing”) and approximately an additional 6,150,000 shares of Common Stock and warrants to purchase up to approximately 2,150,000 shares of Common Stock in a second closing (the “January Closing”) on January 19, 2005 following approval of the January Closing by the Issuers stockholders at a special meeting of stockholders held on January 17, 2005 (the November Closing and the January Closing are collectively referred to as the “November Private Placement” and together with the April Private Placement, the “Private Placements”). Amadeus IIA purchased 173,077 shares of Common Stock at a price of $6.50 and warrants to purchase 60,577 shares of Common Stock with an exercise price of $7.50 per share for a total consideration of approximately $1,125,000.00, Amadeus IIB purchased 115,385 shares of Common Stock at a price of $6.50 and warrants to purchase 40,385 shares of Common Stock with an exercise price of $7.50 per share for a total consideration of approximately $750,002.50, Amadeus IIC purchased 80,769 shares of Common Stock at a price of $6.50 and warrants to purchase approximately 28,269 shares of Common Stock with an exercise price of $7.50 per share for a total consideration of approximately $524,998.50, Amadeus IID purchased 3,846 shares of Common Stock at a price of $6.50 and warrants to purchase 1,346 shares of Common Stock with an exercise price of $7.50 per share for a total consideration of approximately $24,999.00 and Amadeus Affiliates purchased 11,538 shares of Common Stock at a price of $6.50 and warrants to purchase 4,038 shares of Common Stock with an exercise price of $7.50 per share for a total consideration of approximately $74,997.00 at the January Closing. References to and descriptions of the November Purchase Agreement as set forth in this Item 3 are qualified in their entirety by reference to the Purchase Agreement filed as Exhibit 10.69 to the Issuer’s Current Report on Form 8-K filed on November 23, 2005 and is incorporated herein in its entirety by reference.
Item 4. Purpose of Transaction.
     The Funds acquired the Common Stock for investment purposes, and such purchases have been made in the Reporting Persons’ ordinary course of business.
     (a-b) As described in Item 3 above, this statement relates to the Business Combination and the Private Placements. As a result of the Business Combination, the Issuer acquired all of the share capital of Solexa Limited and Solexa Limited became a subsidiary of the Issuer. The Reporting Persons purchased the shares of Common Stock and warrants to purchase Common Stock as set forth in Item 3.
     (c) Not applicable.
     (d) As a result of the Business Combination, certain directors of Solexa Limited became members of the Board of Directors of the Issuer, including Hermann Hauser.
     (e) Other than as a result of the Business Combination described in Item 3 above, not applicable.
     (f) Not applicable.
     (g-i) Not applicable.
     (j) Other than as described above, the Reporting Persons currently have no plan or proposals which relate to, or may result in, any of the matters listed in Items 4(a)-(i) of Schedule 13D (although the Reporting Persons reserve the right to develop such plans).

 


 

Item 5. Interest in Securities of Issuer.
     (a) Following the consummation of the Business Combination and the Private Placements, Amadeus IIA is the owner of record of 2,262,930 shares of Common Stock, Amadeus IIB is the owner of record of 1,508,621 shares of Common Stock, Amadeus IIC is the owner of record of 1,056,036 shares of Common Stock, Amadeus IID is the owner of record of 50,289 shares of Common Stock and Amadeus Affiliates is the owner of record of 150,861 shares of Common Stock, which includes warrants to purchase shares of Common Stock. Collectively, this represents 5,028,737 shares of Common Stock and approximately 13.7% of the outstanding Common Stock, based upon a total of 36,300,335 shares of Common Stock outstanding as of January 20, 2005.
     (b) Number of shares as to which each person named in paragraph (a) above has:
  (i)   sole power to vote or to direct the vote: see line 7 of cover sheets.
 
  (ii)   shared power to vote or to direct the vote: see line 8 of cover sheets.
 
  (iii)   sole power to dispose or to direct the disposition: see line 9 of cover sheets.
 
  (iv)   shared power to dispose or to direct the disposition: see line 10 of cover sheets.
     (c) Except as set forth above, none of the Reporting Persons have effected any transaction in the Common Stock in the last 60 days.
     (d) No other person is known to have the right to receive or the power to direct the receipt of dividends from, or any proceeds from the sale of the shares beneficially owned by any of the Reporting Persons.
     (e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.
     The information provided or incorporated by reference in Item 3 and Item 4 is hereby incorporated by reference.
     To the best of the knowledge of Amadeus Capital and the Funds, there are no other contracts, arrangements, understandings or relationships (legal or otherwise) among the persons named in Item 2 and between such persons and any person with respect to any securities of the Issuer.
Item 7. Material to be filed as Exhibits.
     A. Agreement regarding filing of joint Schedule 13D.

 


 

SIGNATURES
     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: February 17, 2006
             
    AMADEUS CAPITAL PARTNERS LIMITED
 
           
 
  By:   /s/ Hermann Hauser    
 
           
    Name: Hermann Hauser
    Title: Director
 
           
    AMADEUS II ‘A’
    By its Manager, Amadeus Capital Partners Limited
 
           
 
  By:   /s/ Hermann Hauser    
 
           
    Name: Hermann Hauser
    Title: Director
 
           
    AMADEUS II ‘B’
    By its Manager, Amadeus Capital Partners Limited
 
           
 
  By:   /s/ Hermann Hauser    
 
           
    Name: Hermann Hauser
    Title: Director
 
           
    AMADEUS II ‘C’
    By its Manager, Amadeus Capital Partners Limited
 
           
 
  By:   /s/ Hermann Hauser    
 
           
    Name: Hermann Hauser
    Title: Director
 
           
    AMADEUS II ‘D’ GMBH & CO KG
    By its Manager, Amadeus Capital Partners Limited
 
           
 
  By:   /s/ Hermann Hauser    
 
           
    Name: Hermann Hauser
    Title: Director
 
           
    AMADEUS II AFFILIATES FUND LP
    By its Manager, Amadeus Capital Partners Limited
 
           
 
  By:   /s/ Hermann Hauser    
 
           
    Name: Hermann Hauser
    Title: Director

 


 

EXHIBIT INDEX
     A. Agreement regarding filing of joint Schedule 13D.

 


 

Exhibit A
JOINT FILING UNDERTAKING
     Pursuant to Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned agree that the Schedule 13D, and any amendments thereto, filed with respect to the beneficial ownership by the undersigned of the equity securities of Solexa, Inc., is being filed on behalf of each of the undersigned.
Dated: February 17, 2006
             
    AMADEUS CAPITAL PARTNERS LIMITED
 
           
 
  By:   /s/ Hermann Hauser    
 
           
    Name: Hermann Hauser
    Title: Director
 
           
    AMADEUS II ‘A’
    By its Manager, Amadeus Capital Partners Limited
 
           
 
  By:   /s/ Hermann Hauser    
 
           
    Name: Hermann Hauser
    Title: Director
 
           
    AMADEUS II ‘B’
    By its Manager, Amadeus Capital Partners Limited
 
           
 
  By:   /s/ Hermann Hauser    
 
           
    Name: Hermann Hauser
    Title: Director
 
           
    AMADEUS II ‘C’
    By its Manager, Amadeus Capital Partners Limited
 
           
 
  By:   /s/ Hermann Hauser    
 
           
    Name: Hermann Hauser
    Title: Director
 
           
    AMADEUS II ‘D’ GMBH & CO KG
    By its Manager, Amadeus Capital Partners Limited
 
           
 
  By:   /s/ Hermann Hauser    
 
           
    Name: Hermann Hauser
    Title: Director
 
           
    AMADEUS II AFFILIATES FUND LP
    By its Manager, Amadeus Capital Partners Limited
 
           
 
  By:   /s/ Hermann Hauser    
 
           
    Name: Hermann Hauser
    Title: Director

 

-----END PRIVACY-ENHANCED MESSAGE-----